(lp0
S'XOMA to Announce Fourth Quarter and Full Year 2016 Financial Results and Host ... GlobeNewswire  - Mar 14, 2017 BERKELEY, Calif., March 14, 2017  -- XOMA Corporation , a pioneer in the discovery and development of therapeutic antibodies, announced today it will issue its fourth quarter and full year 2016 financial results before&nbsp;...'
p1
aS'XOMA to Present Preclinical Data from its PTH1R Monoclonal Antibodies Program ... GlobeNewswire  - Mar 28, 2017 BERKELEY, Calif., March 28, 2017  -- XOMA Corporation , a pioneer in the discovery and development of therapeutic antibodies, announced today the presentation of data from its PTH1R Monoclonal Antibodies Program&nbsp;...'
p2
aS"XOMA to Present New Strategic Initiatives at the Cowen and Company 37th Annual ... GlobeNewswire  - Feb 28, 2017 BERKELEY, Calif., Feb. 28, 2017  -- XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, announced today that Jim Neal, Chief Executive Officer, will present the company's new&nbsp;..."
p3
aS'XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from ... GlobeNewswire  - Dec 21, 2016 BERKELEY, Calif., Dec. 21, 2016  -- XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, today announced several corporate actions to further streamline its operations to focus on&nbsp;...'
p4
aS"Xoma Corp Trading Well Above Recent Offering Price But Below October Reverse ... Benzinga - Feb 13, 2017 XOMA Corporation  shares are trading higher by $0.70  at $4.73 in Monday's session. The issue bottomed at its higher opening tick of $4.30 and has continued to move higher.XOMA Announces Pricing of $25 Million Registered Offering of Common Stock and ... - GlobeNewswire Xoma Corporation  $25 Million Deal with BVP Partners Explained - StockNewsUnion"
p5
aS"XOMA Announces Reverse Stock Split GlobeNewswire  - Oct 14, 2016 BERKELEY, Calif., Oct. 14, 2016  -- XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, today announced that, at a special meeting of the Company's stockholders held on October 14&nbsp;..."
p6
aS'Stock Returns: Vical Incorporated  versus XOMA Corporation ... CML News - Apr 16, 2017 This is a snapshot to compare the stock returns for Vical Incorporated  versus XOMA Corporation  .'
p7
aS'XOMA Ltd: Odds Improving On This $1 Biotech Lottery Ticket Seeking Alpha - Oct 3, 2015 XOMA Corporation is a late-stage biotechnology company with expertise in allosteric modulation and a portfolio of innovative therapeutic monoclonal antibodies.'
p8
aS"3 Things You Need to Know About XOMA Corp. Motley Fool - Mar 26, 2015 XOMA's product pipeline consists of human and humanized monoclonal antibodies designed to treat metabolic, inflammatory, and cardiovascular diseases."
p9
aS'Trading by the Numbers: Stock Review for XOMA Corporation  BVN - 18 hours ago Investors may be checking on some financial ratios for XOMA Corporation . Currently, the company has a Gross Margin  ratio of 0.194023.'
p10
a.